SHP2 Is Required for BCR-ABL1-Induced Hematologic Neoplasms
S. Gu, A. Sayad, G. Chan, W. Yang, Z. Lu, C. Virtanen, R. A. Van Etten, B. G. Neel
This study shows SHP2 is essential for BCR-ABL1-induced hematologic cancers, affecting proliferation and signaling pathways in pre-B cells.
bioRxiv · Jun 30, 2017Cancer Biology